Rationale: According to general view, aldehyde dehydrogenase-2 (ALDH2) catalyzes the high-affinity pathway of vascular nitroglycerin (GTN) bioactivation in smooth muscle mitochondria. Despite having wide implications to GTN pharmacology and raising many questions that are still unresolved, mitochondrial bioactivation of GTN in blood vessels is still lacking experimental support.Objective: In the present study, we investigated whether bioactivation of GTN is affected by the subcellular localization of ALDH2 using immortalized ALDH2-deficient aortic smooth muscle cells and mouse aortas with selective overexpression of the enzyme in either cytosol or mitochondria.
Methods and Results:Quantitative Western blotting revealed that ALDH2 is mainly cytosolic in mouse aorta and human coronary arteries, with only approximately 15% (mouse) and approximately 5% (human) of the enzyme being localized in mitochondria. Infection of ALDH2-deficient aortic smooth muscle cells or isolated aortas with adenovirus containing ALDH2 cDNA with or without the mitochondrial signal peptide sequence led to selective expression of the protein in mitochondria and cytosol, respectively. Cytosolic overexpression of ALDH2 restored GTN-induced relaxation and GTN denitration to wild-type levels, whereas overexpression in mitochondria (6-fold vs wild-type) had no effect on relaxation. Overexpression of ALDH2 in the cytosol of ALDH2-deficient aortic smooth muscle cells led to a significant increase in GTN denitration and cyclic GMP accumulation, whereas mitochondrial overexpression had no effect. Key Words: adenovirus Ⅲ aldehyde dehydrogenase-2 Ⅲ mitochondria Ⅲ nitroglycerin Ⅲ vasodilation A ldehyde dehydrogenase-2 (ALDH2) has a wellestablished function in the detoxification of reactive aldehydes, in particular ethanol-derived acetaldehyde, in the liver. Because the liver enzyme is almost exclusively located in the mitochondrial matrix space, it is commonly designated as mitochondrial aldehyde dehydrogenase to differentiate it from the cytosolic isoform (ALDH1). 1 In 2002, Stamler et al 2 discovered that vascular ALDH2 catalyzes bioconversion of nitroglycerin to yield 1,2-glycerol dinitrate (GTN) and inorganic nitrite. This reaction appears to be associated with formation of a disulfide in the catalytic site, leading to mechanism-based enzyme inactivation in the absence of an appropriate reductant, like dithiothreitol, 2 dihydrolipoic acid, 3 or the thioredoxin/thioredoxin reductase system. 4 Based on the mitochondrial localization of liver ALDH2, it has been proposed that GTN bioactivation takes place in mitochondria of vascular smooth muscle cells. Reduction of GTN-derived nitrite to nitric oxide (NO) by components of the respiratory chain would then couple ALDH2-catalyzed GTN metabolism to activation of soluble guanylate cyclase (sGC) and vascular relaxation. 2 Mitochondrial GTN bioactivation, supported by the observation that isolated mitochondria generate NO bioactivity from added GTN, 5,6 has been generally accepted in the field and has fo...